диссертации / 108

111

208.The prognostic importance of different definitions of worsening renal function in congestive heart failure [Теxt] / S.S. Gottlieb [et al.] // J. Card Fail. — 2002. — Vol. 8. — P. 136–41.

209.The renin-angiotensin system as a risk factor and terapeutic target for cardiovascular and renal disease [Теxt] / M. Volpe [et al.] // J Am Soc Nephrol. — 2002. Vol. 13 [Suppl 3]. — P. 173–178.

210.TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways [Теxt] / T. Nakagawa [et al.] // Kidney Int. — 2004. — Vol. 66. — P. 605–13.

211.TGF beta1is an organizer of responses to neurodegeneration [Теxt] / C.E. Finch [et al.] // J. Cell Biochem. — 1993, Dec. — Vol. 53 (4). — P. 314–322.

212.Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro [Теxt] / J.M. Fan [et al.] // Kidney Int. — 1999. Vol. 56. P. 1455–67.

213.Ulmer, P.S. Sample requirements for plasma renin activity and immunoreactive rennin [Теxt] / P.S. Ulmer, A.W. Meikle // Clin. Chem. — 2000. — Vol. 46, № 9. — P. 1442–1444.

214.Uttenthal, L.O. NGAL: a marker molecule for the distressed kidney? [Теxt] / L.O. Uttenthal // Clin Lab Int. — 2005. — Vol. 29. — P. 39–41.

215.Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism [Теxt] / A. Tanabe [et al.] // J. Clin. Endocrinol. Metab. — 2003. — Vol. 88. — P. 2489–2494.

216.Vascular function and mild renal impairment in stable coronary artery disease [Теxt] / P. van der Harst [et al.] // Arterioscler Thromb Vasc Biol. — 2006. — Vol. 26 (2). — P. 379–384.

217.Volpe, M. Microalbuminuria screening in patients with hypertension: Recommendations for clinical practice [Теxt] / M. Volpe // Int J Clin Pract. — 2008. — Vol. 62 (1). — P. 97–108.

112

218.Wang, W. Transforming growth factor-beta and Smad signalling in kidney diseases [Теxt] / W. Wang, V. Koka, H.Y. Lan // Nephrology (Carlton). — 2005, Feb. — Vol. 10(1). — P. 48–56.

219.Weber, K.T. Targeting patological remodeling: concepts cardiopro-tection and

reparation [Теxt] / K.T. Weber // Circulation. — 2000. — Vol. 102. —

P.1342–1345.

220.Weinberger, M.H. Salt-sensitive of blood pressure in humans [Теxt] / M.H. Weinberger // Hypertension. — 1996. — Vol. 27. — C. 481–490.

221.World Healh Organization Internasional Society of Hypertension Guidelines for the Management of Hypertension [Теxt] // J. Hypertens. — 1999. — Vol. 17. —

P.151–185.

222.Yokoyama, H. Central role of TGF-beta in the pathogenesis of diabetic nephropathy and macrovascular complications: a hypothesis [Теxt] / H. Yokoyama, T. Decret // Diabet Med. — 1996, Apr. — Vol. 13 (4). — P. 313–320.

223.Zeisberg, M. Renal fibrosis: an update [Теxt] / M. Zeisberg, F. Strutz, G.A. Muller // Curr. Opin. Nephrol. Hypertens. — 2001. — Vol. 10. — P. 315–20.

224.Zhu, S. TGF-beta-1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or AII receptor blocker [Теxt] / S. Zhu, Y. Liu, L. Wang // NDT. — 2008. — Vol. 23. — P. 2941–2946.